[Possible involvement of urotensin II in essential hypertension].
Ikeda
Keiichi
K
Department of Pharmacology, Jikei University School of Medicine.
Tojo
Katsuyoshi
K
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000503:physiopathology; D009200:Myocardial Contraction / Q000187:drug effects; D009569:Nitric Oxide / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D015398:Signal Transduction; D014579:Urotensins / Q000494:pharmacology / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D043562:Receptors, G-Protein-Coupled; C121697:UTS2R protein, human; D014579:Urotensins; C473142:Uts2r protein, rat; D009569:Nitric Oxide; C029677:urotensin II